LAGOSTA SA

Bluebiotech producing bioactive compounds from spiny lobster

LAGOSTA is a Swiss blue biotech company, expert in biomedical chitosan production.

Issue

Chitosan has multiple biotech applications yet to benefit patients for the sole reason that reproducible chitosan is not available.

Solution

By farming European spiny lobsters - Palinurus elephas - in our state-of-the-art indoor fully controlled facility, our approach, enables:
- 5x faster growth than in the wild
- an exclusive, naturally generated, stable raw material: molts (byproducts)
- no seasonal variations of the raw material
- full traceability

This unique raw material & our process produce a cGMP biomedical chitosan with:
- Reproducible biological properties
- High molecular weight > 400 kDa
- High degree of deacetylation DDA>95%
- Compliant with EU and US pharmacopoeia standards

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

No news

Milestone

18.10.2022

Production of the 1st reproducible biomedical chitosan batch

No Jobs

No Awards

LAGOSTA SA

Bluebiotech producing bioactive compounds from spiny lobster

Headquarter:
St-Prex

Foundation Date:
February 2013

Technology:

  • Biotech